3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Burkitt Lymphoma
20
Leukemia, Biphenotypic, Acute
12
Leukemia, Myeloid, Acute
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Osteosarcoma
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia
4
Blast Crisis
4
Lymphoma, Mantle-Cell
3
Lymphoma
3
Down Syndrome
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Rhabdoid Tumor
2
Recurrence
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Juvenile
2
Head and Neck Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Waldenstrom Macroglobulinemia
1
Urothelial Carcinoma of the Bladder
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Interventions
pembrolizumab
44
Carboplatin
35
Paclitaxel
27
Specimen Handling
18
Cyclophosphamide
16
Capecitabine
16
Magnetic Resonance Spectroscopy
14
sacituzumab govitecan
13
Gemcitabine
13
Taxes
12
Biopsy
12
130-nm albumin-bound paclitaxel
11
Albumin-Bound Paclitaxel
9
Doxorubicin
8
olaparib
7
Nivolumab
7
fludarabine
6
Cisplatin
6
eribulin
5
atezolizumab
5
Radiotherapy
5
Docetaxel
5
durvalumab
4
Fulvestrant
4
Epirubicin
4
Bevacizumab
4
veliparib
3
famitinib
3
abemaciclib
3
Vinorelbine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Methotrexate
×
90 days
×
Clear all
No trials found.